Turning the tide on Alzheimer’s disease: Modulation of γ-secretase Review


Authors: Luo, J. E.; Li, Y. M.
Review Title: Turning the tide on Alzheimer’s disease: Modulation of γ-secretase
Abstract: Alzheimer’s disease (AD) is the most common type of neurodegenerative disorder. Amyloid-beta (Aβ) plaques are integral to the “amyloid hypothesis,” which states that the accumulation of Aβ peptides triggers a cascade of pathological events leading to neurodegeneration and ultimately AD. While the FDA approved aducanumab, the first Aβ-targeted therapy, multiple safe and effective treatments will be needed to target the complex pathologies of AD. γ-Secretase is an intramembrane aspartyl protease that is critical for the generation of Aβ peptides. Activity and specificity of γ-secretase are regulated by both obligatory subunits and modulatory proteins. Due to its complex structure and function and early clinical failures with pan inhibitors, γ-secretase has been a challenging drug target for AD. γ-secretase modulators, however, have dramatically shifted the approach to targeting γ-secretase. Here we review γ-secretase and small molecule modulators, from the initial characterization of a subset of NSAIDs to the most recent clinical candidates. We also discuss the chemical biology of γ-secretase, in which small molecule probes enabled structural and functional insights into γ-secretase before the emergence of high-resolution structural studies. Finally, we discuss the recent crystal structures of γ-secretase, which have provided valuable perspectives on substrate recognition and molecular mechanisms of small molecules. We conclude that modulation of γ-secretase will be part of a new wave of AD therapeutics. © 2021, The Author(s).
Keywords: inhibitor; mechanism; γ-secretase; modulator; alzheimer’s disease
Journal Title: Cell and Bioscience
Volume: 12
ISSN: 2045-3701
Publisher: Biomed Central Ltd  
Date Published: 2022-01-04
Start Page: 2
Language: English
DOI: 10.1186/s13578-021-00738-7
PROVIDER: scopus
PMCID: PMC8725520
PUBMED: 34983641
DOI/URL:
Notes: Review -- Export Date: 1 February 2022 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Yueming Li
    132 Li
  2. Joanna Luo
    1 Luo